Mereo BioPharma completes patient enrollment for BPS-804 Phase 2b trial in osteogenesis imperfecta

British specialty biopharma company Mereo BioPharma Group has completed patient enrollment for a Phase 2b clinical trial of its human monoclonal antibody BPS-804, also known ... Read More